Role of Protein Kinase Cδ in Endothelin-Induced Type I Collagen Expression in Cardiac Myofibroblasts Isolated from the Site of Myocardial Infarction
- 1 November 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 311 (2) , 691-699
Abstract
The role of endothelin-1 (ET) in tissue remodeling/fibrogenesis has been demonstrated in various in vitro and in vivo models. Our previous studies have revealed ET-induced expression of type I collagen in cardiac myofibroblasts (myoFb). Here we report that protein kinase Cδ (PKCδ) and mitogen-activated protein kinase/extracellular signal-regulated kinase-1/2 (MAPK/ERK1/2) play a role in ET-induced type I collagen expression using specific pharmacological inhibitors. The present study also reveals the expression of various isoforms of PKC including PKCα, PKCβI, PKCβII, PKCγ, PKCδ, PKCϵ, PKCη, and PKCζ in cardiac myoFb. Our results from mRNA and protein studies demonstrate that calphostin-C, a PKC inhibitor, decreased the ET-induced type I collagen expression suggesting a role for the PKC pathway. Further treatment with rottlerin, a PKCδ isoform-specific inhibitor, demonstrated attenuation of 80 to 90% of type I collagen expression induced by ET. However, Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo[2,3-a]pyrrolo [3,4-c]carbazole]], an inhibitor of Ca2+-dependent PKC isoforms (PKCα and PKCβI), showed little to no effect on ET-stimulated type I collagen expression. Furthermore, the MAPK inhibitor PD98059 (2′-amino-3′-methoxyflavone) attenuated ET-dependent activation of p44/42 MAPK (pERK1/2) and also down-regulated type I collagen expression. Similarly, rottlerin inhibited the activation of p44/42 MAPK (pERK) implicating the involvement of PKC and MAPK/ERK1/2 in ET-induced type I collagen expression. Our protein/DNA array and reverse transcription-polymerase chain reaction results from ET-treated samples showed a significant increase in Sp1 expression. PD98059 and rottlerin decreased ET-induced Sp1 expression, suggesting a possible interaction of Sp1 with PKCδ and MAPK in ET-induced type I collagen expression in cardiac myoFb.Keywords
This publication has 39 references indexed in Scilit:
- Activation of CTP:Phosphocholine Cytidylyltransferase α Expression during the S Phase of the Cell Cycle Is Mediated by the Transcription Factor Sp1Journal of Biological Chemistry, 2003
- Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDRJournal of Molecular and Cellular Cardiology, 2003
- Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling: Presented in part at the 72nd Scientific Session of the American Heart Association, Atlanta, GA, USA, November 7-10, 1999, and published in abstract form (Circulation 1999;100(Suppl. 1):562)Cardiovascular Research, 2002
- Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent PathwayJournal of Biological Chemistry, 2001
- Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252Journal Of Hypertension, 2000
- Increased Protein Kinase C Activity and Expression of Ca 2+ -Sensitive Isoforms in the Failing Human HeartCirculation, 1999
- Modulation of human α1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitroGene, 1998
- Transgenic Gαq overexpression induces cardiac contractile failure in miceProceedings of the National Academy of Sciences, 1997
- Angiotensin II Stimulated Expression of Transforming Growth Factor-β1in Cardiac Fibroblasts and MyofibroblastsJournal of Molecular and Cellular Cardiology, 1997
- Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cellsJournal of Molecular and Cellular Cardiology, 1990